C-reactive protein level indicates AMD risk

Article

People with high blood levels of C-reactive protein may be at higher risk of developing age-related macular degeneration.

People with high blood levels of C-reactive protein may be at higher risk of developing age-related macular degeneration (AMD), according to a report published in October issue of Archives of Ophthalmology.

Sharmila S. Boekhoorn and colleagues from the Erasmus Medical Centre, Rotterdam, the Netherlands collected blood samples and took photographs of the eyes of more than 4,900 people at risk from AMD and followed the group for an average of 7.7 years. During this period, 658 subjects were diagnosed with AMD; 561 with initial stage AMD and 97 with advanced AMD.

It was found that as a person's C-reactive protein level increased the person became more and more likely to develop AMD.

The researchers suggest that lowering C-reactive protein levels may help decrease the risk of developing AMD.

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.